- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
The Cigna Group(CI)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CI
11/13/2026: CI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
The Cigna Group is a major healthcare services company operating through its Evernorth pharmacy solutions and Cigna Healthcare insurance divisions. The company's primary strength lies in its integrated business model and scale in pharmacy benefit management, which drives steady cash flow generation. Its core growth strategy centers on expanding specialty pharmacy services and value-based care partnerships. However, key risks include heavy regulatory scrutiny regarding drug pricing and ongoing exposure to medical cost inflation. Suited for value and dividend-focused investors, market participants should closely monitor legislative developments affecting PBM transparency and medical loss ratios.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Cigna offers steady mid-single-digit top-line growth rather than high-octane hyper-growth. |
| Momentum investor | Strong fit while signal remains positive | Momentum fit is conditional on a positive technical and fundamental upturn signal in the healthcare sector. |
| Value investor | Strong fit | The stock frequently trades at reasonable price-to-earnings multiples relative to its strong cash flow generation. |
| Dividend investor | Strong fit | Cigna provides a reliable and growing dividend supported by robust free cash flow. |
| Low-risk investor | Mixed fit | While defensive, the stock remains subject to headline risks regarding healthcare policy and regulatory scrutiny. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock experiences moderate price swings driven by quarterly medical cost trends and regulatory headlines. |
| Valuation risk | Low | Shares typically trade at reasonable valuations, limiting severe multiple contraction risk. |
| Competition risk (PBM and managed care competition) | Medium / high | Intense rivalry with giants like UnitedHealth and CVS Health shapes market pricing power. |
| Business quality | Strong | The company possesses a durable franchise with entrenched positions in corporate health and pharmacy services. |
| Dividend income | Medium | Payouts are secure and growing, though yields are supplemented heavily by share repurchases. |
| Execution risk | Medium | Management must continuously execute complex pharmacy management and medical cost containment strategies. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 78.26B USD | Price to earnings Ratio 13.1 | 1Y Target Price 344.96 |
Price to earnings Ratio 13.1 | 1Y Target Price 344.96 | ||
Volume (30-day avg) 1.6M shares | Beta 0.25 | 52 Weeks Range 253.96 - 318.05 | Updated Date 11/15/2026 |
52 Weeks Range 253.96 - 318.05 | Updated Date 11/15/2026 | ||
Dividends yield (FY) 2.09% | Basic EPS (TTM) 22.68 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.7%
- Active BUY / eligible
- 69 / 110
- 30-Day BUY Count Change
- +30
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Healthcare Plans
- BUY participation
- 60.0%
- Active BUY / eligible
- 3 / 5
- 30-Day BUY Count Change
- 0
Eligible universe: 5 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -41.74% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Evernorth Health Services | Pharmacy benefit management, specialty pharmacy, home delivery, and health services solutions. | This is the company's primary revenue engine, generating steady cash flows from managing prescription drug programs. |
| Cigna Healthcare | Medical, dental, and supplemental health insurance products for employers and individuals. | Generates revenue through premium collections and fee-based administrative services for employer health plans. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When Before Market | Estimate 7.46 | Actual 7.98 |
Profitability
Profit Margin 2.09% | Operating Margin (TTM) 3.79% |
Management Effectiveness
Return on Assets (TTM) 4.29% | Return on Equity (TTM) 15.65% |
Valuation
Trailing PE 13.1 | Forward PE 8.86 | Enterprise Value 102.17B | Price to Sales(TTM) 0.27 |
Enterprise Value 102.17B | Price to Sales(TTM) 0.27 | ||
Enterprise Value to Revenue 0.36 | Enterprise Value to EBITDA 8.02 | Shares Outstanding 263.50M | Shares Floating 262.20M |
Shares Outstanding 263.50M | Shares Floating 262.20M | ||
Percent Insiders 1.62 | Percent Institutions 91.05 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

